Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × balstilimab × Clear all

NCT03894215 2025-02-20

RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer

Phase 2 Active not recruiting

Uterine Cervical Neoplasms

NCT05033132 2024-03-28

A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer

Phase 2 Withdrawn

Uterine Cervical Neoplasms